Martin Harp

1 week ago | ophthalmologytimes.com | Martin Harp |Katherine Talcott |Hattie Hayes

At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study. The research she presented focused on neovascular age-related macular degeneration (AMD). "This is actually the first phase 2 study looking at a tyrosine kinase inhibitor for wet AMD," Dr. Talcott told the Eye Care Network.

1 week ago | europe.ophthalmologytimes.com | Martin Harp |Hattie Hayes |Nitish Mehta

Editors from the Eye Care Network are onsite at this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah. During the conference, we spoke with Nitish Mehta, MD, an assistant professor at New York University Langone Health in New York, NY. He shared highlights from his research, which documented real-world results of aflibercept 8 mg for patients with diabetic macular oedema (DMO).

1 week ago | modernretina.com | Martin Harp |Hattie Hayes

May 5, 2025By The PRISM clinical trial assesses 4D-150 (4D Molecular Therapeutics) in adults with neovascular age-related macular degeneration, also known as wet AMD. At the 2025 Association for Research in Vision and Ophthalmology (ARVO) annual meeting, Christine Kay, MD, of Vitreoretinal Associates in Gainesville, Florida, shared an update from the PRISM clinical trial. Dr. Kay is a vitreoretinal surgeon and inherited retinal disease specialist.

1 week ago | modernretina.com | Martin Harp |Hattie Hayes

May 5, 2025By In an analysis of the IRIS database, investigators assessed almost 1,200 eyes that had been treated with faricimab. At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, the Eye Care Network spoke with Rishi Singh, MD, vice president and CMO, Cleveland Clinic Martin North and South Hospitals.

1 week ago | ophthalmologytimes.com | Martin Harp |Hattie Hayes |John Tan

Author(s):,Researchers stratified a dataset of more than 100 patients in an emergency department to see which patients may be indicated for retinal artery occlusions. The Association for Research in Vision and Ophthalmology (ARVO) is hosting its annual meeting in Salt Lake City, Utah this year. At the ARVO meeting, researchers' posters and podium presentations cover a wide range of ocular pathologies, diagnostic technologies, and practice modalities.